Patents Assigned to CatAssays
  • Patent number: 9933421
    Abstract: Disclosed herein is a composition for ultrasensitive bioassay applications. The composition includes a plurality of dispersible, nanoparticles having a size less than 500 nm. The nanoparticles contain a metal catalyst or a metal catalyst precursor. The nanoparticles are conjugated to at least one biospecific binding reactant that is selectively reactive with a target analyte. The composition includes a dispersing medium. A method and a kit for conducting bioassays are described.
    Type: Grant
    Filed: August 19, 2013
    Date of Patent: April 3, 2018
    Assignee: CatAssays
    Inventors: Mark Lelental, Henry J. Gysling
  • Publication number: 20150050672
    Abstract: Disclosed herein is a composition for ultrasensitive bioassay applications. The composition includes a plurality of dispersible, nanoparticles having a size less than 500 nm. The nanoparticles are contain a metal catalyst or a metal catalyst precursor. The nanoparticles are conjugated to at least one biospecific binding reactant that is selectively reactive with a target analyte. The composition includes a dispersing medium. A method and a kit for conducting bioassays is described.
    Type: Application
    Filed: August 19, 2013
    Publication date: February 19, 2015
    Applicant: CatAssays
    Inventors: Mark Lelental, Henry J. Gysling
  • Patent number: 7820394
    Abstract: The invention relates to ultrasensitive bioanalytical assays based on the use of high-gain catalytic chemical amplification methods. The ultrasensitive bioanalytical assays of the invention utilize high gain catalytic chemical amplification methods to detect the presence and to quantify the concentrations of target analytes labeled with specific binding reagents or biomarkers comprising a catalyst or a catalyst precursor.
    Type: Grant
    Filed: December 2, 2005
    Date of Patent: October 26, 2010
    Assignee: CatAssays
    Inventors: Mark Lelental, Henry J. Gysling